Trial Information
Non-interventional Study of Avastin in 1st Line Metastatic Colorectal Cancer
Inclusion Criteria:
- Adult patients, >/= 18 years of age
- Histologically confirmed metastatic colorectal cancer without prior chemotherapy in
the metastatic setting
Exclusion Criteria:
- Contraindications for Avastin according to the locally approved package insert
(version 7 April 2006)
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Dosage/schedule of 1st-line Avastin
Outcome Time Frame:
approximately 3 years
Safety Issue:
No
Principal Investigator
Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
Hoffmann-La Roche
Authority:
South Africa: Medicines Control Council of South Africa
Study ID:
ML22399
NCT ID:
NCT01674907
Start Date:
March 2010
Completion Date:
April 2012
Related Keywords:
- Colorectal Cancer
- Colorectal Neoplasms